Sign in

CIK 0000093314

  • Non-accelerated filer
  • Smaller reporting company

VOLITIONRX LTD

Sign in to watch
Ticker
VNRX
Exchange
NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911949078
Phone
+1 512-774-8930
Business address
1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
Former names
VOLITIONRX LTD, STANDARD CAPITAL CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-01 Rootsaert Rodney Gerard Secretary Grant or award +7,908 143,026
2025-03-01 Plummer Nicholas GC - Volition Diagnostics Grant or award +12,483 177,628
2025-03-01 Nguyen Kim Director Grant or award +9,893 86,409
2025-03-01 Batchelor Ann-Louise Group Chief Marketing Officer Grant or award +14,233 128,942
2025-03-01 Colman Alan Director Grant or award +14,840 245,364
2025-03-01 Kway Jasmine CEO - Singapore Volition Grant or award +16,708 182,780
2025-03-01 Retter Andrew Chief Medical Officer Grant or award +10,142 137,617
2025-03-01 Rubin Ethel Director Grant or award +9,893 33,541
2025-03-01 Butera Salvatore Thomas CEO - Volition Veterinary Grant or award +19,300 312,890
2025-03-01 Forterre Gael Chief Commercial Officer Grant or award +5,523 162,704
2025-03-01 Innes Guy Archibald Director Grant or award +19,786 686,871
2025-03-01 Hughes Terig Chief Financial Officer Grant or award +13,969 390,221
2025-01-29 Colman Alan Director Returned to the company · Stock Option (Right to Buy) −25,000 0
2025-01-29 Colman Alan Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2025-01-29 Reynolds Cameron John President and CEO Returned to the company · Stock Option (Right to Buy) −50,000 0
2025-01-29 Reynolds Cameron John President and CEO Grant or award · Stock Option (Right to Buy) +50,000 50,000
2025-01-29 Innes Guy Archibald Director Returned to the company · Stock Option (Right to Buy) −25,000 0
2025-01-29 Innes Guy Archibald Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2025-01-29 Kway Jasmine CEO -Singapore Volition Returned to the company · Stock Option (Right to Buy) −50,000 0
2025-01-29 Kway Jasmine CEO -Singapore Volition Grant or award · Stock Option (Right to Buy) +50,000 50,000

Page 7 of 11 · 216 trades